Unitide Medicals Profile
Key Indicators
- Authorised Capital ₹ 5.00 M
as on 18-06-2024
- Paid Up Capital ₹ 5.00 M
as on 18-06-2024
- Company Age 22 Year, 9 Days
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 9.00 M
as on 18-06-2024
- Revenue -23.31%
(FY 2022)
- Profit 23.72%
(FY 2022)
- Ebitda 34.14%
(FY 2022)
- Net Worth -19.25%
(FY 2022)
- Total Assets 0.18%
(FY 2022)
About Unitide Medicals
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 5.00 M and a paid-up capital of Rs 5.00 M.
The company currently has active open charges totaling ₹9.00 M.
George Alexander, Koshy Varghese, Madhav Asok, and One other member serve as directors at the Company.
- CIN/LLPIN
U85110KL2002PTC015806
- Company No.
015806
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
11 Dec 2002
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Ernakulam
Industry
Company Details
- Location
Kollam, Kerala, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Unitide Medicals?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Madhav Asok | Managing Director | 21-Mar-2024 | Current |
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
George Alexander  | Director | 11-Dec-2002 | Current |
| Koshy Varghese | Director | 11-Dec-2002 | Current |
| Rajamma Thankappan | Director | 30-Jun-2005 | Current |
Financial Performance and Corporate Structure Insights of Unitide Medicals.
Unitide Medicals Private Limited, for the financial year ended 2022, experienced significant reduction in revenue, with a 23.31% decrease. The company also saw a substantial improvement in profitability, with a 23.72% increase in profit. The company's net worth observed a substantial decline by a decrease of 19.25%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Unitide Medicals?
In 2021, Unitide Medicals had a promoter holding of 60.74% and a public holding of 39.26%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Uniserve Distributors Private LimitedActive 29 years 10 monthsGeorge Alexander and Koshy Varghese are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Karnataka Bank Limited Creation Date: 27 Oct 2007 | ₹9.00 M | Open |
How Many Employees Work at Unitide Medicals?
Unlock and access historical data on people associated with Unitide Medicals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Unitide Medicals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Unitide Medicals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
